Navigation Links
Gentium's Defibrotide Highlighted in Poster Presentation at World,Congress of Nephrology

Gentium, S.p.A.
Gary G. Gemignani, Chief Financial Officer
212-332-1666
ggemignani@gentium.com
or
Investor Relations Contacts:
U.S.:
Lippert/Heilshorn & Associates
Anne Marie Fields, 212-838-3777
afields@lhai.com
Bruce Voss, 310-691-7100
bvoss@lhai.com
or
Italy:
Burson-Marsteller
Luca Ricci Maccarini, +39 02.721431
luca_maccarini@it.bm.com


'"/>




Page: 1 2 3

Related medicine technology :

1. Gentiums Defibrotide Seen as Active in Multiple Myeloma
2. Gentiums Defibrotide Highlighted in Two Poster Presentations at American Association for Cancer Research Annual Meeting
3. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
4. Isotechnikas Lead Drug, ISA247, To Be Highlighted at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
5. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
6. Alfacells Onconase Highlighted in Latest Edition of Handbook of Therapeutic Antibodies
7. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
8. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
9. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
10. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
11. Savient Pharmaceuticals Announces Acceptance of Two Gout-Related Abstracts for Poster Presentation at the European League Against Rheumatism (EULAR) 2007 Annual Congress

Post Your Comments:
(Date:12/1/2009)...Newswire/ -- CeloNova BioSciences, Inc., a provide...ces and of specialty implants, today announced tha... medical director of Baptist Cardiac & Vascula...TANIA(TM) Stent System with NanoThin Polyzene®...ions Conference to be held at the Hotel David Inte...
(Date:12/1/2009)...ec. 1 Galenea Corp. and Otsuka Pha...extension of their research and development collab...ases the collaboration term to seven years and bri...90 million. The companies have been working toget...g and developing first-in-class therapies for schi...
(Date:12/1/2009)...Newswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Am...licensed to Chrono Nutraceuticals LLC exclusive ri...ed release dietary supplements using SCOLR,s propr...ion, SCOLR granted Chrono rights to manufacture an...n a nonexclusive basis. Chrono paid SCOLR $25,000...
Breaking Medicine Technology:Dr. Barry Katzen to Present CATANIA(TM) Coronary Stent Data in Tel Aviv 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3SCOLR Pharma, Inc. Licenses Dietary Supplements 2SCOLR Pharma, Inc. Licenses Dietary Supplements 3Mark W Parrish Joins Mylans Board of Directors 13758 1Mark W Parrish Joins Mylans Board of Directors 13758 2Jacobs Receives Contract for San Francisco General Hospital and Trauma Center Rebuild Program 55823 1Jacobs Receives Contract for San Francisco General Hospital and Trauma Center Rebuild Program 55823 2Jacobs Receives Contract for San Francisco General Hospital and Trauma Center Rebuild Program 55823 3U S Compression Therapy Market to Reach 241 16 Billion in 2015 Finds Frost 26 Sullivan 55819 1U S Compression Therapy Market to Reach 241 16 Billion in 2015 Finds Frost 26 Sullivan 55819 2U S Compression Therapy Market to Reach 241 16 Billion in 2015 Finds Frost 26 Sullivan 55819 3U S Compression Therapy Market to Reach 241 16 Billion in 2015 Finds Frost 26 Sullivan 55819 4
...rred Dose for Optimal Efficacy and Tolerability; S...ustralia and BEDMINSTER, N.J., May 22 /PRNewswire-...ical-stage specialty pharmaceutical,company focuse...apies for,pain and central nervous system (CNS) di...or Q8003IR establishing a 12mg/8mg morphine and ox...
... of rEEG(R) Guided Medication Study Demonstrates a...order Symptoms, COSTA MESA, Calif., May 22 CNS R...today the results of a study presented,at the Amer...eting by Dr.,James Greenblatt, M.D., Chief Medical...try and Eating Disorder Programs. The poster prese...
Other Medicine Technology:QRxPharma Releases Additional Phase 3 Data for Q8003IR 'Dual Opioid' Pain Therapy 2QRxPharma Releases Additional Phase 3 Data for Q8003IR 'Dual Opioid' Pain Therapy 3QRxPharma Releases Additional Phase 3 Data for Q8003IR 'Dual Opioid' Pain Therapy 4CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 2CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 3CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 4CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 5CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 6
(Date:12/1/2009)...S, Dec. 1 The American ...igh School Student Symposium at the New Orleans Ma...The symposium, which encourages an interest in hem...arch, is held in conjunction with the Society,s 51...he opportunity to explore research on sickle cell ...
(Date:12/1/2009)...J., Dec. 1 A national survey revea...deal for their babies and themselves but at the sa...or them and their families. ,, See video from H.../ ,, The survey of mothers of children aged 12...made their infant feeding decision prior to going ...
(Date:12/1/2009)...lopment of simple screening test, expert says , ... finding that could lead to a simple blood test to...ntified immune system markers that indicate early-...cancer. , The researchers examined gene express...h non-small cell lung cancer and a control group o...
(Date:12/1/2009)...because pandemic,s course remains unpredictable ,...U.S. health official said Tuesday that H1N1 swine ..., but many experts agreed the virus could return i...espread in 32 states -- down from 43 states the we...U.S. Centers for Disease Control and Prevention (C...
(Date:12/1/2009)...ver thought you could quit smoking while you,re st...undbreaking new system for quitting is easy, painl...ty eight days your cravings and desire to smoke wi... (PRWEB) December 1, 2009 -- Izabella had tried t...tion to nicotine, smoking at least a pack a day. ,...
Breaking Medicine News(10 mins):Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 3Health News:VIDEO from Medialink and HealthyWomen: Breast, Bottle or Both? 2Health News:Gene 'Signature' May Point to Lung Cancer 2Health News:Swine Flu Waning, But Could Return 2Health News:Swine Flu Waning, But Could Return 3Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 3
... Webcast will Explore the Evolutio...elisting and Discuss Today,s Best Practices Approa... Scottsdale, Ariz. (PRWEB) August 6, 2008 -- htt...l leader in security management, today announced t...
...g rituximab causes considerable kidney injury heal...mon form of kidney disease, according to a study a...al Journal of the American Society Nephrology (CJA...some patients. , Membranous nephropathy (also kno...
...S, Aug. 5 ATS Medical, Inc.,(Nasdaq: ATSI ), man...,surgery products, announced today that it will pa...l Growth Conference at the InterContinental Hotel ...wscom.com/cgi-bin/prnh/20040202/ATSILOGO ), Atten...
...n, Altarum Institute VP and Chairman of the Black ...o City Business Council on AIDS, WASHINGTON, Aug....stitute and a prominent leader and advocate on HIV...il on,AIDS conference is a satellite meeting of th...
... MA, Aug. 5 /PRNewswire-FirstCall/ - NUCRYST Pharm...eloper and manufacturer of medical,products that f...o release,its financial results for the second qua...sults for the quarter., Conference call details:...
...mature early without positive feedback more likely... Aug. 5 (HealthDay News) -- Positive parenting can...hrough puberty early, says a study by researchers ...p track of their activities are more likely to be ...
Other Medicine News:Health News:Lumension Security To Showcase Vulnerability Management Expertise With Whitehatworld.com Webcast 2Health News:Lumension Security To Showcase Vulnerability Management Expertise With Whitehatworld.com Webcast 3Health News:Targeted drug therapy found effective in patients with common form of immune-mediated kidney disease 2Health News:ATS Medical to Participate at the 28th Annual Canaccord Adams Global Growth Conference 2Health News:NUCRYST Pharmaceuticals to Release Second Quarter 2008 Financial Results on Tuesday, August 12, 2008 2Health News:Nurturing Parents Can Cut Risk of Aggression in Girls 2
The EXTENDED FIT
The PANORAMA
Jarrod Goggle
Clip-On
Medicine Products: